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Rift Valley fever virus (RVFV) encodes one major virulence factor, the NSs protein. NSs suppresses host
general transcription, including interferon (IFN)-b mRNA synthesis, and promotes degradation of the
dsRNA-dependent protein kinase (PKR). We generated a novel RVFV mutant (rMP12-NSsR173A)
speciﬁcally lacking the function to promote PKR degradation. rMP12-NSsR173A infection induces early
phosphorylation of eIF2a through PKR activation, while retaining the function to inhibit host general
transcription including IFN-b gene inhibition. MP-12 NSs but not R173A NSs binds to wt PKR. R173A
NSs formed ﬁlamentous structure in nucleus in a mosaic pattern, which was distinct from MP-12 NSs
ﬁlament pattern. Due to early phosphorylation of eIF2a, rMP12-NSsR173A could not efﬁciently accumulate
viral proteins. Our results suggest that NSs-mediated host general transcription suppression occurs
independently of PKR degradation, while the PKR degradation is important to inhibit the phosphorylation
of eIF2a in infected cells undergoing host general transcription suppression.
& 2012 Elsevier Inc. All rights reserved.Introduction
Rift Valley fever virus (RVFV) belonging to the family Bunya-
viridae, genus Phlebovirus is a mosquito-borne zoonotic pathogen
endemic to sub-Saharan Africa, and has spread into Egypt,
Madagascar, Saudi Arabia and Yemen (Pepin et al., 2010;
Swanepoel and Coetzer, 2004). Humans infected with RVFV suffer
from febrile illness with occasional complications such as hemor-
rhagic fever, encephalitis or blindness (Ikegami and Makino,
2011). RVFV infection of pregnant ruminants causes high rates
of abortion and fetal malformation (Swanepoel and Coetzer,
2004). Because of its potential impact on public health and
agriculture, RVFV is classiﬁed as Category A Priority pathogen
by NIH/NIAID, and overlap select agent by CDC/USDA in the U.S.
(Bird et al., 2009; Mandell and Flick, 2010). Currently, there are no
commercially available vaccines outside endemic countries, and
there are no effective therapeutics to treat RVF patients. MP-12 isll rights reserved.
gy, The University of Texas
. Galveston, TX 77555-0436,
.the only strain excluded from select agent rule, and can be
handled in BSL-2 laboratories.
RVFV genome is comprised of a tripartite negative-stranded
RNA genome named S-, M-, and L-segments (Schmaljohn and
Nichol, 2007). In addition to viral structural proteins; i.e., N, L, Gn
and Gc proteins, RVFV encodes two nonstructural proteins (NSs
and NSm) and the less characterized 78 kD protein. NSs protein,
encoded in the S-segment, is a major virulence factor of RVFV, and
has three functions; (1) suppression of the general host transcrip-
tion by sequestering TFIIH p44 subunit proteins (Le May et al.,
2004) and by promoting the degradation of TFIIH p62 subunit
proteins (Kalveram, Lihoradova and Ikegami, 2011), (2) degradation
of dsRNA-dependent protein kinase (PKR) (Habjan et al., 2009;
Ikegami et al., 2009), and (3) inhibition of the IFN-b promoter
activation through sin3A-associated protein (SAP30) (Le May et al.,
2008). MP-12 strain encodes functional NSs gene, which inhibits
host general transcription and promotes degradation of PKR
(Billecocq et al., 2008; Ikegami et al., 2009; Ikegami et al., 2006;
Kalveram, Lihoradova and Ikegami, 2011). In addition, NSs is
responsible for cell cycle arrest at either G0/G1 or S phase, as well
as DNA damage response via ataxia-telangiectasia mutated (ATM)
(Austin et al., 2012; Baer et al., 2012). NSs interacts with pericen-
tromeric g-satellite sequence and induces defect of chromosome
cohesion and segregation (Mansuroglu et al., 2009).
Fig. 1. rMP12-NSsR173A virus does not promote PKR degradation. Plaque phe-
notype of MP-12 (left) and rMP12-NSsR173A virus (right) on VeroE6 cells at 3 dpi.
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cycle. Habjan et al. showed that the RVFV clone 13 strain, lacking a
functional NSs, replicates efﬁciently in PKR-knockout mice (Habjan
et al., 2009). Our study demonstrated that cells infected with rMP12-
rLuc (lacking NSs) resulted in increased levels of eIF2a phospho-
rylation, as compared to those infected with parental MP-12 (encod-
ing NSs), in the presence of actinomycin D (ActD; transcription
inhibitor) (Ikegami et al., 2009). On the other hand, phosphorylation
of eIF2a was signiﬁcantly suppressed in the presence of MP-12 NSs
or PKRDE7 (a dominant-negative form of human PKR). These results
suggest that the PKR degradation by MP-12 NSs alleviates the
negative effect of host transcription suppression to maintain viral
translation. Although RVFV NSs encodes both host transcription
suppression function and PKR degradation function, it is not clear
whether host transcription suppression occurs independently of PKR
degradation, or vice versa, and NSs-mediated transcription suppres-
sion creates cellular environment which requires PKR degradation
for an efﬁcient viral translation.
We hypothesize that host transcription suppression and IFN-b
gene suppression occur independently of PKR degradation, while
PKR degradation is important to inhibit eIF2a phosphorylation
under NSs-mediated host transcription suppression. In this study,
we generated and characterized a novel NSs mutant that does not
promote PKR degradation while inhibiting host general transcrip-
tion. Our results suggest that NSs-mediated host transcription
suppression occurs independently of PKR degradation, and cells
undergoing host general transcription by NSs induce early eIF2a
phosphorylation by viral replication when PKR degradation does
not occur. Thus, PKR degradation plays an important role for an
efﬁcient viral protein synthesis in RVFV-infected cells.Results
Generation of MP-12 NSs mutants by alanine substitution.
To study the signiﬁcance of PKR degradation in cells infected with
RVFV, we tried to generate an MP-12 encoding a mutant NSs that
does not promote PKR degradation yet inhibits host general tran-
scription. Since no structural analyses are available for the NSs
protein, we performed random screening of NSs mutants. Initially,
11 serial in-frame truncations of 25 amino acids were introduced
into MP-12 NSs, and the resulting NSs mutants were functionally
analyzed. Those NSs truncated mutants lacked PKR degradation
function, as well as IFN-b gene suppression (Head, Kalveram and
Ikegami, 2012). In an attempt to generate mutants lacking only one
of known functions of NSs, we next randomly substituted one or two
charged residues of NSs with alanine to create single or double point
mutants. Among 10 recombinant MP-12 viruses characterized
(R15A/R16A, R47A, R103A, D124A, E156A/D157A, R164A, E169A,
R173A, D184A, E188A), R15A/R16A, R47A, R103A, D124A, R164A and
R173A mutants inhibited IFN-b gene in MRC-5 cells. Among the
mutants inhibiting IFN-b gene, only R173A did not promote degra-
dation of PKR in VeroE6 cells, while R15A/R16A, R47A, R103A, D124A
and R164A still promoted PKR degradation in VeroE6 cells (data not
shown). We designated the R173A mutant as rMP12-NSsR173A, and
further characterized the phenotypes to know the NSs functions in
detail. We ﬁrst characterized the plaque phenotype because MP-12
forms varied sizes of plaques with clear cytopathic effect (CPE), while
MP-12 lacking NSs forms turbid plaques with minimum CPE
(Ikegami et al., 2006). R15A/R16A, R47A, D124A, E156A/D157A,
R164A, E188A formed MP-12-like plaques, while E169A and D184A
formed uniformly turbid plaques, and R103A formed a mixture of
MP-12-like plaques and turbid plaques (data not shown). The
rMP12-NSsR173A formed uniformly smaller plaques than those of
MP-12 with clear cytopathic effect (CPE) (Fig. 1).The rMP12-NSsR173A induces PKR-mediated eIF2a phosphorylation
We examined the viral protein synthesis and eIF2a phospho-
rylation level in cells infected with rMP12-NSsR173A . Type-I IFN-
competent mouse embryonic ﬁbroblast cells (MEF/wt cells) were
mock-infected or infected with MP-12, rMP12-C13type, rMP12-
NSsR173A, or rMP12-mPKRN167 virus at an moi of 3. Cell lysates
were collected at 6 and 12 hpi, and analyzed by Western blot
(Fig. 2A and B). We included rMP12-C13type or rMP12-mPKRN167
(Lihoradova et al., 2012) which lack all NSs functions or speciﬁcally
inhibit mouse PKR while still inducing IFN-b, respectively, as
controls. We used mouse MEF cells to be able to further characterize
the effect in cells lacking PKR (MEF/PKR0/0 cells) in later experi-
ments. As expected, cells infected with MP-12 caused a degradation
of PKR at 6 hpi, and phosphorylation status of eIF2a was not
signiﬁcantly changed at 6 or 12 hpi. Cells infected with rMP12-
C13type increased the abundance of phosphorylated eIF2a (1.63
times) at 12 hpi, and the accumulation of Gn and Gc was 25% and
31% less than those of MP-12-infected cells, respectively, while
accumulation of N protein was still similar to that in cells that were
infected with MP-12 . On the other hand, cells that were infected
with rMP12-NSsR173A showed a visible band of PKR, while phos-
phorylated eIF2a was signiﬁcantly increased by 1.87 times
(p¼0.0185, vs. MP-12) at 6 hpi, and the accumulation of Gn, Gc,
and N proteins was 53%, 41%, and 38% less than those of MP-12-
infected cells at 6 hpi, respectively. At 12 hpi, cells infected with
rMP12-NSsR173A still had abundant phosphorylated eIF2a and less
abundant Gn, Gc, and N. Levels of phosphorylated eIF2a in cells
infected with rMP12-mPKRN167 virus were not signiﬁcantly
increased, and the abundance of Gn, Gc, and N proteins were similar
to those of MP-12-infected cells. These results suggested that
rMP12-NSsR173A does not induce PKR degradation, and increases
the abundance of phosphorylated eIF2a faster than rMP12-C13type .
Since the abundance of R173A NSs proteins was lower than that of
MP-12 NSs at 6 and 12 hpi, it was possible that low level of R173A
NSs accumulation could result in a lack of PKR degradation. To
address this, we analyzed early time points (i.e., 3, 4 and 5 hpi inMEF/
wt cells mock-infected or infected with MP-12 or rMP12-NSsR173A).
At 3 hpi, PKR abundance was lower in cells infected with MP-12 than
those infected with rMP12-NSsR173A at 3 hpi (unpaired t-test,
p¼0.029) due to an increase of PKR abundance in cells infected with
rMP12-NSsR173A (Fig. 2C and D). However, the abundance of PKR
was clearly decreased at 4 hpi in cells infected with MP-12 compared
to mock-infected cells (unpaired t-test, p¼0.033 vs. mock-infected
cells at 4 hpi). Thus, MP-12 NSs could start degrading PKR as early as
4 hpi in MEF/wt cells. We compared the PKR level of MP-12-infected
cells at 4 hpi and that of rMP12-NSsR173A-infected cells at 5 hpi. The
abundance of R173A N and NSs at 5 hpi was approximately 82.6%
and 55.9% of that of MP-12 N and NSs at 4 hpi, respectively. The
abundance of PKR in cells infected with rMP12-NSsR173A at 5 hpi
was signiﬁcantly higher than that in cells infected with MP-12 at
4 hpi (unpaired t-test, p¼0.033). Compared to mock-infected cells at
Fig. 2. Status of eIF2a and viral translation in MEF cells. MEF/wt cells were mock-infected or infected with indicated viruses at an moi of 3, and the cell lysates were
harvested at indicated time points, and Western blotting was performed to detect indicated protein accumulations. (A) Abundance of PKR, eIF2a, phosphorylated eIF2a
(Ser51), viral N and NSs proteins, Flag-mPKRN167, and b-actin in cells mock-infected or infected with MP-12, rMP12-C13type (C13type), rMP12-NSsR173A (R173A), or
rMP12-mPKRN167 (mPKRN167) at 6 and 12 hpi. Signal intensity of viral proteins (N, Gn and Gc) in cells infected with MP-12 was used as the scale to measure the others
and considered 100%. Asterisk (*) represents a nonspeciﬁc band. (B) The relative abundance of phosphorylated eIF2a at 6 and 12 hpi. The density of phosphorylated eIF2a
normalized to total eIF2a in mock-infected cells is represented as 100%. Asterisk represents statistical signiﬁcance (unpaired t-test, *po0.05, **po0.01). (C) Abundance of
PKR, eIF2a, phosphorylated eIF2a (Ser51), viral N and NSs proteins and b-actin in cells mock-infected or infected with MP-12, rMP12-NSsR173A (R173A) at 3, 4 and 5 hpi.
(D) The relative abundance of PKR, phosphorylated eIF2a, N and NSs in cells infected with MP-12 or rMP12-NSsR173A at 3, 4 and 5 hpi. The density of PKR, phosphorylated
eIF2a (normalized to total eIF2a) in mock-infected cells, or that of N or NSs in MP-12-infected cells at 3 hpi were represented as 100% for PKR, eIF2aP, N or NSs,
respectively. Asterisk represents statistical signiﬁcance (unpaired t-test, *po0.05, ns; not signiﬁcant). In B and D, means þ/ standard deviation of three independent
experiments are shown as a graph, while representative data of three independent experiments are shown in A and C.
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infected cells at 4 hpi, and it was increased by 9% in rMP12-
NSsR173A-infected cells at 5 hpi, respectively. In addition, cells
infected with MP-12 at 3 hpi showed 84% of NSs abundance
compared to R173A NSs at 5 hpi, yet slightly decreased PKR abun-
dance by 12% although the difference was not statistically signiﬁcant.
Thus, a lack of PKR degradation was most probably not due to
abundance of R173A NSs. We also conﬁrmed that rMP12-NSsR173A
could induce accumulation of phosphorylated eIF2a as early as 5 hpi
(Fig. 2D). The results suggest that rMP12-NSsR173A does not promote
PKR degradation and induces the phosphorylation of eIF2a by 5 hpi,
which inhibits the accumulation of viral proteins.
MP-12 replication is negatively affected by a lack of PKR degradation
We next tested viral replication levels of MP-12, rMP12-
C13type, rMP12-NSsR173A, or rMP12-mPKRN167 virus in MEF/wt
cells and MEF/PKR0/0 cells (MEF cells lacking PKR) (Fig. 3). The
replication of rMP12-NSsR173A or rMP12-C13type in MEF/wt cellswas not signiﬁcantly decreased compared to that of MP-12 at an
moi of 1.0, while it was signiﬁcantly decreased at an moi of 0.01
(Fig. 3A). On the other hand, rMP12-mPKRN167 could replicate as
efﬁciently as MP-12 in MEF/wt cells at both high and low moi
(Fig. 3A). The replication of rMP12-NSsR173A or rMP12-C13type
was not decreased in MEF/PKR0/0 cells both at an moi of 0.01 or 1.0
(Fig. 3B). We also tested the replication of rMP12-NSsR173A in
human MRC-5 cells. In MRC-5 cells, replication of rMP12-NSsR173A
or rMP12-C13type was decreased both at high and low moi
compared to that of MP-12 (Fig. 3C). Thus, the results suggest that
the replication levels of rMP12-NSsR173A and rMP12-C13type are
decreased due to a lack of PKR degradation in infected cells. We also
noted that the replication of rMP12-NSsR173A was less efﬁcient in
human MRC-5 cells than in mouse MEF/wt cells.
The rMP12-NSsR173A NSs does not interact with PKR
To further characterize the lack of PKR degradation by rMP12-
NSsR173A, we analyzed the molecular interaction of NSs with
Fig. 3. Replication of rMP12-NSsR173A. MEF/wt cells (A) or MEF/PKR0/0 cells (B) were mock-infected or infected with MP-12, rMP12-C13type, rMP12-NSsR173A, or
rMP12-mPKRN167 at an moi of 1.0 or 0.01, and culture supernatants were collected at 16 hpi or 72 hpi, respectively, to determine the viral titer by plaque assay of VeroE6
cells. (C) MRC-5 cells were infected with MP-12, rMP12-C13type or rMP12-NSsR173A at moi of 3.0 or 0.01, and virus titer at 16 hpi or 72 hpi were measured, respectively.
Mean þ/ standard deviations of three independent experiments are shown in the graph. Unpaired Student’s t-test was performed to compare to the value of MP-12:
**po0.01, *po0.05.
Fig. 4. Co-precipitation of PKR with rMP12-NSs-SF and rMP12-NSsR173A-SF. 293
cells were mock-infected or infected with rMP12-NSs-SF (a tandem repeat of
Strep-tag and Flag-tag at the C-terminus of NSs) or rMP12-NSsR173A-SF at an moi
of 3. Cell lysates were collected at 5 hpi, and NSs-SF was precipitated by using
Strep-Tactin magnetic beads. Western blotting was performed to detect, NSs-SF
(anti-Flag antibody) or b-actin.
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rMP12-NSs-SF (a tandem repeat of Strep-tag and Flag-tag at the
C-terminus of NSs) or rMP12-NSsR173A-SF at an moi of 3. Cell
lysates were collected at 5 hpi, and NSs-SF was precipitated by
using Strep-Tactin magnetic beads. We collected cells at 5 hpi
because cells infected with rMP12-NSs-SF do not completely
degrade PKR at this time point. We conﬁrmed abundant precipi-
tation of NSs-SF and R173 NSs-SF, while the amount of PKR input
was much smaller in rMP12-NSs-SF samples than rMP12-
NSsR173A-SF samples. PKR was co-precipitated with MP-12
NSs-SF, suggesting the interaction of NSs with PKR (Fig. 4). On
the other hand, R173A NSs-SF did not co-precipitate PKR, inspite
of an abundant precipitation of R173A NSs and higher levels of
PKR than cells infected with rMP12-NSs-SF (Fig. 4). The result
suggests that R173A NSs lacks the ability to interact with PKR.
The rMP12-NSsR173A NSs inhibits IFN-b gene expression
To understand the functional difference of cells infected with
MP-12 lacking NSs from those infected with rMP12-NSsR173A,
we next characterized the residual transcription suppression
function of rMP12-NSsR173A . At ﬁrst, we tested whether
rMP12-NSsR173A virus inhibits the activation of host IFN-b
promoter. MEF/wt cells or MEF/PKR0/0 cells were infected at an
moi of 3 with MP-12, rMP12-C13type, rMP12-NSsR173A or
rMP12-mPKRN167, and total RNA was extracted at 7 hpi. We
included MEF/PKR0/0 cells and rMP12-mPKRN167 virus to deter-
mine if PKR is required for IFN-b gene up-regulation . Northern
blot was performed to detect the accumulation of IFN-b or ISG56mRNA (Fig. 5). Both rMP12-C13type and rMP12-mPKRN167,
which lack functional NSs expression, induced accumulation of
IFN-b and ISG56 mRNA in MEF/wt cells and MEF/PKR0/0 cells. On
the other hand, MEF/wt cells or MEF/PKR0/0 cells infected with
MP-12 or rMP12-NSsR173A virus did not induce IFN-b or ISG56
mRNA. The results suggested that R173A NSs inhibits IFN-b
Fig. 5. rMP12-NSsR173A virus inhibits IFN-bmRNA synthesis. (A) MEF/wt cells or MEF/PKR0/0 cells were mock-infected or infected with MP-12, rMP12-C13type (C13type), rMP12-
NSsR173A (R173A), or rMP12-mPKRN167 (N167), or (C) MRC-5 cells were mock-infected or infected with rMP12-rLuc, MP-12 or rMP12-NSsR173A virus at an moi of 3. Total RNA
was harvested at 7 hpi. Northern blotting was performed with the strand-speciﬁc RNA probes to detect IFN-b or ISG56 mRNA, or RVFV anti-sense S-segment/ N mRNA.
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dispensable for IFN-b gene activation by MP-12 lacking NSs.
We also tested IFN-b mRNA induction in human MRC-5 cells.
MRC-5 cells were mock-infected or infected with MP-12, rMP12-
rLuc (a control lacking NSs), which encodes rLuc in place of NSs,
or rMP12-NSsR173A at an moi of 3. At 7 hpi, total RNA was
extracted. IFN-b mRNA and ISG56 mRNA were detected in cells
infected with rMP12-rLuc, while they were not induced in cells
infected with MP-12 or rMP12-NSsR173A (Fig. 5B).
We noted slowly migrating RNA bands derived from MEF/wt
cells and MEF/PKR0/0 cells infected with MP-12, rMP12-NSsR173A
and rMP12-mPKRN167 as well as MRC-5 cells infected with
rMP12-NSsR173A . On the other hand, ISG56 mRNA, which is
inducible by IFN-b, was not increased in MEF/wt, MEF/PKR0/0 or
MRC-5 cells infected with MP-12 or rMP12-NSsR173A . We did
not further characterize the slowly migrating bands reactive to
IFN-b probe in this study because it is beyond the scope of study.
The rMP12-NSsR173A inhibits host general transcription
We subsequently analyzed the effect of rMP12-NSsR173A on
host general transcription. MEF/wt cells were mock-infected or
infected with MP-12, rMP12-C13type, rMP12-NSsR173A or
rMP12-mPKRN167 viruses at an moi of 3 (Fig. 6A). Cells were
treated with the uridine analog 5-ethynyluridine (EU) at 16 hpi,
and ﬁxed at 17 hpi. The incorporated EU was covalently linked to
Alexa Fluor 594 coupled-azide (red signal) by click reaction (Jao
and Salic, 2008), and cells were further reacted with anti-RVFV
antibodies (green signal). Mock-infected cells actively incorpo-
rated the EU into nascent RNA in the nucleus or nucleoli, as
shown by strong red signals. Such incorporation of EU was not
detectable in the presence of ActD, suggesting that the incorpora-
tion of EU is speciﬁc to RNA transcription. Cells infected with
rMP12-C13type or rMP12-mPKRN167 actively incorporated EU,
while those infected with MP-12 or rMP12-NSsR173A virus did
not incorporate EU as efﬁciently as cells infected with rMP12-C13
type or rMP12-mPKRN167 virus. These results suggested that
both MP-12 and rMP12-NSsR173A suppress host general tran-
scription, while rMP12-C13type and rMP12-mPKRN167 lack the
ability to suppress host transcription in MEF/wt cells.
We also analyzed the level of EU incorporation quantitatively
by using 293 cells as described previously (Kalveram, Lihoradova
and Ikegami, 2011). Mock-infected 293 cells or those infected
with MP-12, rMP12-C13type, or rMP12-NSsR173A were treated
with EU at 8 hpi, ﬁxed at 9 hpi, and stained with Alexa Fluor 647
coupled-azide and anti-RVFV antibody before analysis by
ﬂuorescence-activated cell sorting (FACS) (Fig. 6B). We also usedrMP12-PKRDE7, which encodes dominant-negative human PKR in
place of NSs (Ikegami et al., 2009). The rationale to use rMP12-
PKRDE7 instead of rMP12-mPKRN167 for the control is that
dominant-negative suppression of PKR is host species-speciﬁc
(Li and Koromilas, 2001). Most cells infected with rMP12-
NSsR173A showed reduced EU incorporation, while 19.3% of total
cells (22% of RVFV-infected cell population) incorporated EU at a
similar level to that of rMP12-C13type -infected cells. Thus, we
concluded that rMP12-NSsR173A retains host general transcrip-
tion suppression function, as opposed to rMP12-C13type which
lacks all NSs functions.
PKR plays an important role for eIF2a phosphorylation induced by
rMP12-NSsR173A
Although we observed that rMP12-NSsR173A induced an early
eIF2a phosphorylation (Fig. 2), it might be due to cellular stress
responses induced by an accumulation of misfolded NSs proteins.
To know the involvement of PKR in eIF2a phosphorylation, we
analyzed the effect of R173A NSs expression on eIF2a phosphor-
ylation. Human Hec1B cells were mock-infected or infected with
rMP12-rLuc or rMP12-PKRDE7 at an moi of 3. Then, cells were
mock-transfected or immediately transfected with in vitro
synthesized RNA encoding R173A NSs. We used in vitro synthe-
sized RNA rather than plasmid DNA because R173A NSs can
inhibit the transcription of own gene. Cells were collected at
16 hpi. We used type-I IFN unresponsive Hec1B cells to avoid PKR
activation by RNA transfection (Constantinescu et al., 1995). The
expression of R173A NSs without RVFV replication did not induce
PKR phosphorylation, while it induced slight increase in eIF2a
phosphorylation compared to mock-treated cells (Fig. 7A). The
result suggests that PKR activation is negligible by the transfec-
tion of in vitro synthesized RNA in Hec1B cells. On the other hand,
a combination of R173A NSs expression and the replication of
rMP12-rLuc induced clearly detectable PKR and eIF2a phosphor-
ylation, and slightly decreased the synthesis of R173A NSs from
transfected R173A NSs RNA (Fig. 7A). The phosphorylation of PKR
was inhibited in a combination of R173A NSs expression and the
replication of rMP12-PKRDE7, and the level of eIF2a phosphor-
ylation was signiﬁcantly decreased (Fig. 7A and B). These results
suggest that PKR is responsible for inducing eIF2a phosphoryla-
tion in cells infected with rMP12-NSsR173A .
The R173A NSs forms ﬁlamentous structure in nucleus
Since the ﬁlamentous structure of NSs may play an important role
in host general transcription suppression and IFN-b gene inhibition
Fig. 6. Host general transcriptional suppression by RVFV MP-12 mutants. (A) Incorporation of uridine analog 5-ethynyluridine (EU) into nascent RNA is tested in MEF/wt
cells. MEF/wt cells were mock-infected or infected with MP-12, rMP12-C13type, rMP12-NSsR173A, or rMP12-mPKRN167 at an moi of 3, and 1 mM EU was added into the
culture at 16 hpi for 1 h. Then, cells were ﬁxed and stained with Alexa Fluor 594-coupled azide (red). The cells were further stained with anti-RVFV antibodies and Alexa
Fluor 488-conjugated anti-mouse IgG (green). As a control, mock-infected cells were co-treated with actinomycin D (ActD) at 5 mg/ml with 1 mM EU for 1 h at 16 hpi.
(B) Fluorescence-activated cell sorting (FACS) analysis was performed in 293 cells. 293 cells were mock-infected or infected with MP-12, rMP12-C13type, or rMP12-
NSsR173A at an moi of 3 and treated with 0.5 mM EU at 8 hpi for 1 h. The control cells were co-treated with ActD (5 mg/ml) at 8 hpi for 1 h. Incorporated EU was stained
with Alexa Fluor 647-azide, and viral antigens were stained with anti-RVFV antibodies. Cells were then analyzed by ﬂow cytometry on the LSRII Fortessa. (For
interpretation of the references to color in this ﬁgure, the reader is referred to the web version of this article.)
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cellular localization of R173A NSs. However, the synthesis of R173A
NSs could be inhibited at transcriptional level (Fig. 6) and transla-
tional level via PKR-mediated eIF2a phosphorylation (Fig. 2). To
maximize the expression of R173A NSs in cells, MEF/PKR0/0 cells
were mock-transfected or transfected with in vitro synthesized RNA
encoding MP-12 NSs or R173A NSs. At 14 h post transfection, cells
were ﬁxed with methanol, and subjected into indirect immunoﬂuor-
escent assay using anti-RVFV antibody. As shown in Fig. 8, anti-RVFV
antibody did not react to mock-transfected cells (Fig. 8A). Cellstransfected with MP-12 NSs RNA was speciﬁcally stained with anti-
RVFV antibody (Fig. 8B and C). Interestingly, the shade of NSs ﬁlament
could be detected in DAPI staining only (Fig. 8B, arrows), suggesting
MP-12 NSs sequesters chromatin structure. MP-12 NSs also accumu-
lated in cytoplasm (Fig. 8C and D), which is consistent with previous
study (Yadani et al., 1999). Although the accumulation level was low,
R173A NSs could be detected in both nucleus and cytoplasm, and
formed ﬁlamentous structure inside nucleus, which was different in
shape from that of MP-12 NSs, and showed irregular mosaic-like
pattern (Fig. 8E and F).
Fig. 7. R173A NSs-mediated eIF2a phosphorylation is decreased in the presence of dominant-negative PKR. (A) Human Hec1B cells were mock-infected or infected with
rMP12-rLuc or rMP12–PKRDE7 at an moi of 3. Then, cells were mock-transfected or immediately transfected with in vitro synthesized RNA encoding R173A NSs. Cells were
collected at 16 hpi, and the abundance of PKR, phosphorylated eIF2a (Ser51), total eIF2a, R173A NSs, N and b-actin was analyzed by Western blot. (B) The relative
abundance of phosphorylated eIF2a and NSs were analyzed. The density of phosphorylated eIF2a (normalized to total eIF2a) or NSs in mock-infected cells which are
transfected with R173A NSs RNA is represented as 100%. The mean þ/ standard deviation of three independent experiments is shown as a graph. Asterisk represents
statistical signiﬁcance (unpaired t-test, *po0.05, **po0.01).
Fig. 8. Cellular localization of MP-12 NSs and R173A NSs. MEF/PKR0/0 cells were mock-transfected or transfected with in vitro synthesized RNA encoding MP-12 NSs or
R173A NSs. At 14 h post transfection, cells were ﬁxed with methanol, and indirect immunoﬂuorescent assay using anti-RVFV antibody was performed. Mock-transfected
cells (A) or cells transfected with MP-12 NSs RNA (B–D) or R173A NSs RNA (E and F) were incubated with anti-RVFV antibody (A and C–F) or normal mouse serum (B).
Nuclei were visualized by DAPI. Scale (50 mm) is shown as while bars, and enlarged image is shown as an inset in E. White arrow(s) indicate the area unstained with DAPI
with ﬁlamentous shadow (B), or cells corresponding to inset image (E).
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In this study, we hypothesized that host transcription suppres-
sion and IFN-b gene suppression occur independently of PKR
degradation, while PKR degradation is important to inhibit eIF2a
phosphorylation under NSs-mediated host transcription suppres-
sion. We screened out a novel recombinant MP-12 NSs point
mutants named rMP12-NSsR173A . The rMP12-NSsR173A forms
small plaques in VeroE6 cells (Fig. 1), does not promote PKRdegradation (Fig. 2), yet induces host general transcription sup-
pression (Fig. 6) including IFN-b gene (Fig. 5). We found that MP-12
NSs but not R173A NSs interacts with wt PKR (Fig. 4), while R173A
NSs forms ﬁlamentous structure with a mosaic pattern which is
distinct from MP-12 NSs ﬁlamentous structure (Fig. 8). Cells
supporting the replication of rMP12-NSsR173A but not MP-12
induced early phosphorylation of eIF2a through PKR activation
(Figs.2 and 7). On the other hand, the replication of rMP12-
NSsR173A was inefﬁcient in MEF/wt cells, but not in MEF/PKR0/0
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degradation is important to inhibit early phosphorylation of eIF2a
and contributes to an efﬁcient viral translation in infected cells that
undergo host general transcription suppression.
The small plaque of rMP12-NSsR173A is distinct from the large
turbid plaque of rMP12-C13type (Ikegami et al., 2006). The CPE
(typically change in cell shape and cell detachment from plate) of
rMP12-NSsR173A is similar to that of MP-12, while rMP12-
C13type only causes minimum cell detachment. Since R173A
NSs but not C13type NSs retains host transcription suppression
activity, it is likely that MP-12 cytopathic effect might be caused
by host general transcription suppression. Alternatively, unchar-
acterized NSs functions may contribute to such CPE in infected
cells. Among all the mutants tested, only rMP12-NSsR173A
formed uniform small plaques in VeroE6 cells. This suggests that
a combination of host general transcription suppression and
active PKR in infected cells affects the spread of RVFV.
We observed that rMP12-C13type and rMP12-NSsR173A repli-
cate inefﬁciently in MEF/wt cells and MRC-5 cells (Fig. 3);
(1) rMP12-C13type induces type-I IFNs and other antiviral genes
including PKR in response to IFN stimulation, while also inducing
eIF2a phosphorylation at relatively late time in infection (Fig. 2B)
(2) rMP12-NSsR173A does not induce type-I IFNs and does not
respond to type-I IFN signaling due to host general transcription
suppression, while inhibiting viral protein synthesis by inducing
eIF2a phosphorylation at early time in infection. Although it is
difﬁcult to analyze all the factors in two different cellular
environment which affect infectious virus production, our data
showed that rMP12-NSsR173A replication was recovered due to a
lack of PKR activation (Fig. 3A). Thus, it indicates that PKR
degradation plays a role in promoting efﬁcient viral replication
in cells undergoing general transcription suppression, and the
result is consistent with previous studies using RVFV and that
encoding nonfunctional NSs (Habjan et al., 2009; Ikegami et al.,
2009).
The introduction of alanine might cause the misfolding of NSs,
and induce ER stress responses in infected cells (Zhao and
Ackerman, 2006), which might induce eIF2a phosphorylation
earlier than rMP12-C13type independent of PKR action (Fig. 2).
We found that there was no dramatic increase in PKR and eIF2a
phosphorylation caused by the expression of R173A NSs itself
(Fig. 7). On the other hand, cells infected with rMP12-rLuc in the
presence of R173A NSs induced eIF2a phosphorylation, while it
did not occur by infection with rMP12-PKRDE7, which expresses a
dominant-negative form of PKR (Fig. 7). These results suggest that
eIF2a phosphorylation induced by replication of rMP12-
NSsR173A occurs by PKR-dependent manner.
Since rMP12-NSsR173A replicated less efﬁciently than MP-12,
it was difﬁcult to know whether the absence of PKR degradation
is due to an insufﬁcient accumulation of NSs required for PKR
degradation. However, we did not observe any signiﬁcant
decrease of PKR in cells infected with rMP12-NSsR173A inspite
of the accumulation of R173A NSs to comparable level to that of
MP-12 NSs (Fig. 2C and D). We also tested the over-expression of
R173A NSs, yet the over-expression of R173A NSs did not promote
PKR degradation (Fig. 7). Furthermore, we conﬁrmed that R173A
NSs does not interact with wt PKR (Fig. 4). Thus, our results
indicate that rMP12-NSsR173A indeed lacks the PKR degradation
function, and that the decreased expression of R173A NSs is the
effect, rather than the cause, of the increased phosphorylation. On
the other hand, it is not clear why R173A mutation resulted in a
loss of PKR degradation function. It is possible that NSs exerts PKR
degradation through domain containing aa.173. Since arginine is
a substrate of methylation or acetylation, the involvement such
post-translational modiﬁcation with R173A mutation might be
also important for PKR degradation.In this study, we developed and characterized a novel recom-
binant MP-12 that does not promote degradation of PKR, while
inhibiting host general transcription including IFN-b gene sup-
pression. Host general transcription suppression including IFN-b
gene occurs independently of PKR degradation, and PKR degrada-
tion plays an important role in inhibiting early eIF2a phosphor-
ylation in infected cells undergoing host general transcription
suppression by NSs.Materials and methods
Media, cells, and viruses
Mouse embryonic ﬁbroblast (MEF) cells (kindly provided by
Dr. Bryan R.G. Williams at Monash University), MRC-5 (human
diploid hung embryonic) cells, VeroE6 (African green monkey
kidney) cells, HEK 293 (human embryonic kidney) cells and
Hec1B (human endometrial carcinoma) cells were maintained in
Dulbecco’s modiﬁed minimum essential medium (DMEM) con-
taining 10% fetal calf serum (FCS). BHK/T7-9 cells that express T7
RNA polymerase (Ito et al., 2003) were grown in MEM-alpha
containing 10% FCS. Penicillin (100 U/ml) and streptomycin
(100 mg/ml) were added to the media. BHK/T7-9 cells were
selected in medium containing 600 mg/ml hygromycin. MP-12
viral stock was passaged twice in VeroE6 cells. The rMP12-
C13type, virus encoding the NSs gene with a 69% truncation
(Ikegami et al., 2006), has been described previously. The rMP12-
NSsR173A encodes NSs with an alanine substitution at aa.173.
The rMP12-mPKRN167 encodes the N-terminus of mouse PKR
from aa.1–167 with an N-terminal Flag-tag in place of MP-12 NSs
(Lihoradova et al., 2012). These recombinant MP-12s were recov-
ered from BHK/T7-9 cells as described previously (Ikegami et al.,
2006) and passaged once in VeroE6 cells. Virus titers were
determined by plaque assay in VeroE6 cells. Lyophilized MP-12
vaccine was reconstituted and passaged once in MRC-5 cells.
Plasmid
To make a PCR fragment encoding the NSs ORF of rMP12-
NSsR173A, PCR fragments was performed with the following
primer sets: (1) HpavNSF: AGT TGT TAA CAT GGA TTA CTT TCC
TGT GAT ATC TGT TGA TTT GCA G and 173AR: GGT CAA TCC CTG
CGA GGA TGG CCT CAG, (2) 173AF: CTG AGG CCA TCC TCG CAG
GGA TTG ACC and SpevNSR: CGC TAC TAG TCT AAT CAA CCT CAA
CAA ATC CAT C (restriction enzyme sites are underlined). The
second PCR was performed with the two PCR fragments obtained
above with the primer set of HpavNSF and SpevNSR. The PCR
fragment encoding NSs of R173A was digested with HpaI and SpeI
and inserted into the NSs ORF of pProT7-vS(þ), cut with HpaI and
SpeI as described previously (Ikegami et al., 2006). The resulting
plasmid was designated pProT7-S(þ)-NS/R173A. To generate the
RNA probes to detect mouse IFN-b mRNA or mouse ISG56 mRNA,
we cloned a part of mouse IFN-b or mouse ISG56 between KpnI
and HindIII of the PSPT18 plasmid after ampliﬁcation of PCR
fragments from ﬁrst-strand cDNA from wild-type MEF cells that
were infected with rMP12-C13type (7 hpi). The primers that were
used for PCR ampliﬁcation of mouse IFN-b or mouse ISG56 are as
follows; KpnmIFNb-F: GAA GGG TAC CGC TCG GAC CAC CAT CCA
GGC GTA G, HindmIFNb-R: GGC TAA GCT TAT GAA CAA CAG GTG
GAT CCT CCA CGC, KpnmISG56F: GGG TGG TAC CGC TCC ACT TTC
AGA GCC TTC GCA AAG CAG, HindmISG56R: TAC AAA GCT TAT
GGG AGA GAA TGC TGA TGG TGA CCA GG (restriction enzyme
sites are underlined). Human ISG56 probe was synthesized by
using pCRII-ISG56 plasmid (kindly provided by Dr.Kui Li,
University of Tennessee Health Science Center).
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The rMP12-NSsR173A viruses was recovered by using a
plasmid combination of pProT7-S(þ)-NS/R173A, pProT7-M(þ),
pProT7-L(þ), pT7-IRES-vN, and pT7-IRES-vL in BHK/T7-9 cells, as
described previously (Ikegami et al., 2006).
Northern blot analysis
Total RNA was extracted from infected or mock-infected cells
using TRIzol reagent. Denatured RNA was separated on 1%
denaturing agarose–formaldehyde gels and transferred onto a
nylon membrane (Roche Applied Science). Northern blot analysis
was performed as described previously with strand-speciﬁc RNA
probes to detect RVFV anti-sense S-segment/ N mRNA, IFN-b
mRNA (human or mouse), or ISG56 mRNA (human or mouse)
(Ikegami et al., 2009; Ikegami et al., 2005).
Western blot analysis
Western blot analysis was performed as described previously
(Ikegami et al., 2009). The membranes were incubated with anti-
human PKR monoclonal antibody (BD biosciences), anti-mouse
PKR antibody (B-10, Santa Cruz Biotech.), anti-PKR Phospho
(pT446) antibody (Epitomics Inc.), anti-eIF2-alpha antibody (Cell
Signaling Tech.), anti-phospho-eIF2-alpha (ser51) antibody (Cell
Signaling Tech.), anti-RVFV mouse polyclonal antibody (a kind gift
from Dr. R.B.Tesh, UTMB), anti-DYKDDDDK tag antibody (Cell
Signaling Tech.), anti-Flag M2 monoclonal antibody (Sigma), or
anti-actin goat polyclonal antibody (I-19; Santa Cruz Biotech.)
overnight at 4 1C and with secondary antibodies for 1 h at room
temperature.
Analysis of viral growth
MEF cells were infected with viruses at a multiplicity of
infection (moi) of 3, 1 or 0.01 at 37 1C for 1 h. Culture super-
natants were harvested at 16 hpi (moi of 3 or 1) or 72 hpi (moi of
0.01), and the viral titer was measured by plaque assay. The
growth titers are shown as mean þ/ standard deviation from
three independent experiments.
Analysis of general transcription
MEF/wt cells were mock-infected or infected with MP-12,
C13type, R173A, or N167 at an moi of 3. At 16 hpi, 1 mM
5-ethynyluridine (EU) was added directly into the cell culture,
and cells were incubated for 1 h. As a control, cells were treated
with 5 mg/ml of ActD to inhibit cellular RNA synthesis for 1 h with
1 mM EU (Ikegami et al., 2009). Cells were washed with PBS and
ﬁxed with 125 mM Pipes pH 6.8, 10 mM EGTA, 1 mM magnesium
chloride, 0.2% Triton X-100, and 3.7% formaldehyde for 30 min at
room temperature. After rinsing with TBS once, cells were stained
at room temperature for 30 min with 100 mM Tris pH 8.5, 1 mM
CuSO4, 10 mM Alexa Fluor 594-coupled azide (Invitrogen), and
100 mM ascorbic acid. The addition of ascorbic acid will reduce
copper (II) and produce copper (I) in situ, where copper catalyzes
a covalent reaction between a ﬂuorescent azide and an alkyne of
EU (click reaction) (Jao and Salic, 2008). After staining, cells were
washed 4 times with TBS containing 0.5% Triton X-100 and then
reacted with anti-RVFV antibody that was kindly provided by
Dr. R.B. Tesh (1:500), followed by the staining with Alexa Fluor
488-conjugated anti-mouse IgG and DAPI. Cells were imaged with
ﬂuorescent microscopy to detect cellular RNA that incorporated
EU in 1 h. Fluorescence-activated cell sorting (FACS) analysis was
performed in 293 cells. 293 cells were mock-infected or infectedwith MP-12, rMP12-C13type, or rMP12-NSsR173A at an moi of
3 and treated with 0.5 mM EU at 8 hpi for 1 h. The control cells
were co-treated with ActD (5 mg/ml) at 8 hpi for 1 h. Incorporated
EU was stained with Alexa Fluor 647-azide, and viral antigens
were stained with anti-RVFV antibodies. Cells were then analyzed
by ﬂow cytometry on the LSRII Fortessa (BD Biosciences).
Co-afﬁnity precipitation
SF (Strep-Flag)-tagged protein was precipitated with Strep-
Tactin magnetic beads (Qiagen). 293 cells were mock-infected or
infected with either rMP12-NSs-SF or rMP12-NSsR173A-SF at an
moi of 3 and harvested at 5 hpi. Lysis was performed in 20 mM
Tris pH 7.6, 0.1% Triton X-100, 150 mM NaCl, 1 mM EDTA, 1
complete protease inhibitors (Roche) and 100 U/ml Benzonase
using 3 cycles of freeze-thaw . Cleared lysates (15 min,
13000 rpm, 4 1C) were incubated with 50 ml Strep-Tactin mag-
netic beads (Qiagen) for 2 h at 4 1C in an end-over-end rotor.
Precipitates were washed 3 times in lysis buffer, boiled in SDS-
PAGE sample buffer and analyzed by Western blot.
In vitro RNA synthesis
The pcDNA3.1mycHisA plasmid encoding MP-12 NSs or R173A
NSs was linearized, and in vitro transcribed by using a mMES-
SAGE mMACHINE T7 Ultra kit (Ambion) according to manufac-
turer’s instruction.
Transfection
Transfection of in vitro synthesized RNA was performed by
using TransIT-mRNA Transfection Kit (Mirus) according to man-
ufacturer’s instruction.
Indirect immunoﬂuorescent assay (IFA)
MEF/PKR0/0 cells were mock-transfected or transfected with
in vitro synthesized RNA encoding MP-12 NSs or R173A NSs. At
14 h post transfection, cells were ﬁxed with methanol at room
temperature for 20 min. Then, cells were dried for 5 min, and
blocked with PBS containing normal goat IgG (Santa Cruz Biotech,
sc-2028, 1:1000) at 37 1C for 30 min. Cells were incubated with
anti-RVFV mouse antibody (kind gift from Dr. R.B.Tesh, University
of Texas Medical Branch) (1:500 in PBS with normal goat IgG
1:1000) at 37 1C for 1 h, and subsequently incubated with Alexa
Fluor 594 goat anti-mouse IgG (HþL) (Life Technologies) (1:1000
in PBS) at 37 1C for 1 h. After washing with PBS, DNA was stained
with 4’,6’-diamidino-2-phenylindole (DAPI) (SlowFade Gold Anti-
fade Reagent with DAPI, Life Technologies) to visualize nuclei.
Cells were observed under Olympus IX71 microscope with a DP71
camera, and the image was detected in DP manager software.
Statistical analysis
The statistical analyses were performed by using the Graphpad
Prism 5.03 program (Graphpad Software Inc.). Unpaired Student’s
t-test was used for the comparison of two subjects.Acknowledgments
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